2L
22NW LP’s Lifecore Biomedical LFCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Sell |
264,180
-1,490,981
| -85% | -$128M | 14.25% | 2 |
|
|
2025
Q1 | $29.8M | Hold |
1,755,161
| – | – | 20% | 1 |
|
|
2024
Q4 | $31.1M | Hold |
1,755,161
| – | – | 19.65% | 2 |
|
|
2024
Q3 | $23.7M | Hold |
1,755,161
| – | – | 19.83% | 2 |
|
|
2024
Q2 | $24M | Hold |
1,755,161
| – | – | 20.48% | 2 |
|
|
2024
Q1 | $9.32M | Hold |
1,755,161
| – | – | 8.03% | 4 |
|
|
2023
Q4 | $10.9M | Hold |
1,755,161
| – | – | 7.08% | 5 |
|
|
2023
Q3 | $13.3M | Hold |
1,755,161
| – | – | 9.44% | 5 |
|
|
2023
Q2 | $17M | Hold |
1,755,161
| – | – | 10.6% | 4 |
|
|
2023
Q1 | $6.63M | Hold |
1,755,161
| – | – | 4.08% | 10 |
|
|
2022
Q4 | $11.4M | Hold |
1,755,161
| – | – | 6.14% | 7 |
|
|
2022
Q3 | $15.6M | Buy |
1,755,161
+412,945
| +31% | +$3.67M | 8.82% | 3 |
|
|
2022
Q2 | $13.4M | Buy |
1,342,216
+118,306
| +10% | +$1.18M | 7.1% | 5 |
|
|
2022
Q1 | $14.2M | Buy |
1,223,910
+735
| +0.1% | +$8.51K | 5.15% | 8 |
|
|
2021
Q4 | $13.6M | Buy |
1,223,175
+369,874
| +43% | +$4.11M | 4.2% | 10 |
|
|
2021
Q3 | $7.87M | Buy |
853,301
+303,042
| +55% | +$2.79M | 2.34% | 16 |
|
|
2021
Q2 | $6.19M | Buy |
+550,259
| New | +$6.19M | 1.66% | 24 |
|